Ordónez-Rubiano Edgar Gerardo, García-Chingaté Cristian C, Rodríguez-Vargas Saney, Cifuentes-Lobelo Hernando A, Perilla-Cepeda Tito A
Neurosurgery Department, Fundación Universitaria De Ciencias De La Salud, Hospital de San Jose/Hospital Infantil Universitario de San José.
Cureus. 2017 Jul 20;9(7):e1494. doi: 10.7759/cureus.1494.
The glossopharyngeal neuralgia (GPN) constitutes approximately 0.2-1.3% of all facial pain syndromes. The GPN is a syndrome of neuropathic pain characterized by paroxysmal pain episodes localized in the posterior tongue, tonsil, throat, or external ear canal. The first-line treatment is pharmacological. Patients who are refractory to medical therapy can be treated surgically with microvascular decompression (MVD) or sectioning the IX nerve and the upper rootlets of the X nerve. We aim to describe the technical nuances of MVD of the IX cranial nerve with a targeted inferior mini-craniotomy in a patient with a neurovascular compression.
Zotero 插件